HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
OGI
Organigram Global Inc.
OGI's fundamentals are strong: revenue grew 38% and its operating margin improved to −2.2%, though free cash flow was negative. Its PE isn't a useful guide right now because of how its recent earnings were reported.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
OGI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Weak | |
| Healthy |
OGI's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is weak.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
OGI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 1.9x | $0.83 | — |
| Cheap | 8x | $3.58 | +331% |
| Fair | 14x | $6.30 | +659% |
| Expensive | 28x | $12.62 | +1421% |
Historical ranges are pointers, not guarantees.
OGI's PE is 1.9x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
OGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OGI has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
OGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.45 | +$0.45 |
| Q1 2026 | -$0.13 | -360% |
| Q4 2025 | $0.10 | +$0.49 |
| Q3 2025 | -$0.15 | +$0.23 |
| Q2 2025 | -$0.00 | +$0.61 |
| Q2 2024 | -$0.61 | +$1.34 |
| Q2 2023 | -$1.95 | -$1.63 |
| Q1 2023 | -$0.10 | +$0.25 |
OGI has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS's revenue has grown year over year every quarter since late 2021: $890M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
OGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $74.4M | +49% |
| Q1 2026 | $42M | -8.9% |
| Q4 2025 | $44.6M | +49% |
| Q3 2025 | $56.3M | +79% |
| Q2 2025 | $49.8M | +72% |
| Q1 2025 | $46.1M | +74% |
| Q4 2024 | $30M | +17% |
| Q3 2024 | $31.4M | -2.9% |
OGI's revenue is growing: $74M last quarter, up 49% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5% | +8 points |
| Q1 2026 | -16% | -4.8 points |
| Q4 2025 | -5.4% | +11 points |
| Q3 2025 | 1.5% | +0.9 points |
| Q2 2025 | -3% | +9.3 points |
| Q1 2025 | -12% | +29 points |
| Q4 2024 | -16% | +28 points |
| Q3 2024 | 0.6% | +86 points |
OGI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over OGI on cash generation, producing positive trailing cash flow while its opponent burns cash.
OGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.7M | -177% |
| Q1 2026 | -$4.9M | +$11.3M |
| Q4 2025 | -$12.7M | -$8.6M |
| Q3 2025 | -$483.7K | -110% |
| Q2 2025 | $3.5M | +$6.9M |
| Q1 2025 | -$16.3M | -$9.4M |
| Q4 2024 | -$4.1M | -194% |
| Q3 2024 | $4.9M | +$21.3M |
OGI has burned cash in almost every quarter: −$21M over the past year, against −$12M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over OGI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
OGI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.8% | +5M shares |
| 1 year | +2% | +2.6M shares |
| 3 years | +71% | +56.6M shares |
| 5 years | +142% | +80.2M shares |
| Available history | +262% | +98.8M shares |
OGI has 137M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
OGI hasn't bought back shares in the past year.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has the edge over OGI on leverage, with a lower net debt burden relative to earnings.
OGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | -8.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -7.3x | Net Cash |
| Q2 2025 | -7.0x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q1 2023 | -4.0x | Net Cash |
| Q4 2022 | -3.9x | Net Cash |
OGI's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
OGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.6 | Neutral |
| Stochastic | 4.9 | Oversold |
OGI's weekly RSI is 34 (neutral) and its Stochastic is 5 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
OGI PE vs Healthcare Sector
| Metric | OGI | Sector median | Relative |
|---|---|---|---|
| PE | 1.9x | 26x | 93% below |
| PE % | 0 | 29 | 29 pts below |
OGI is trading at 1.9x earnings, a 93% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
OGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.94 | 12% below |
| 20 week MA | $1.01 | 18% below |
| 50 week MA | $1.26 | 34% below |
| 100 week MA | $1.35 | 39% below |
| 200 week MA | $1.59 | 48% below |
OGI is in a downtrend: it's below all five of its weekly moving averages, and 48% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over OGI on returns for 2026, with the stronger performance.
OGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.40 | $5.68 | -40% |
| 2021 | $5.68 | $8.00 | +41% |
| 2022 | $8.00 | $3.12 | -61% |
| 2023 | $3.12 | $1.31 | -58% |
| 2024 | $1.31 | $1.62 | +24% |
| 2025 | $1.62 | $1.79 | +10% |
| 2026 YTD | $1.79 | $0.83 | -54% |
OGI has finished lower in three of the last six years. It's down 54% so far in 2026.